HCPCS Level IIdrugActive
J9177
Inj enfort vedo-ejfv 0.25mg
BETOS: O1E
Effective: 2020-07-01
Description
Injection, enfortumab vedotin-ejfv, 0.25 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Padcev
Manufacturer
Pfizer Inc
HCPCS Dosage
0.25 MG
Billing Units
80.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.